Ocumetics Announces Completion of First Tranche of Debenture Private Placement for Net Proceeds of CA$2.82 Million
Medical Device Investing Ocumetics Technology: Pioneering Vision Enhancement with the Ocumetics Accommodating Lens
Life Science Investing Ocumetics Continues to Meet Significant Development Milestones; Lens Design Optimized for Upcoming First in Human Study
Life Science Investing Ocumetics Welcomes Dr. Doyle Stulting and Dr. Bart McRoberts to Board of Directors
